Amgen shared a post on LinkedIn:
“Clinical trials are essential to transforming scientific discovery into new medicines for patients.
Strengthening the U.S. clinical research ecosystem can help accelerate patient access to innovation while reinforcing America’s leadership in biomedical science.
We appreciate the U.S. Department of Health and Human Services (HHS) for convening a Clinical Trials Roundtable.
Advancing policies and practices that reduce operational barriers to clinical research, expand patient access to research opportunities and support more efficient trial execution can help bring innovations to patients faster while maintaining rigorous scientific standards.”
Other articles featuring Amgen on OncoDaily.